Volume 19, Number 3—March 2013
Research
Effects of Vaccine Program against Pandemic Influenza A(H1N1) Virus, United States, 2009–2010
Figure 1

Figure 1. . . Weekly number of clinical cases of influenza A(H1N1)pdm09 virus infection, the number of vaccine doses administered, and the estimated number of cases averted over time because of the vaccination program. Midranges shown for epidemic curve and clinical cases; ranges provided in Table 3.
1Current affiliation: Merck & Co., Inc., Lansdale, Pennsylvania, USA.